Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells (Q38932655)

7 September 2017

title

Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells (English)

1 reference

7 September 2017

main subject

hepatocellular carcinoma

1 reference

María L Bacigalupo

1

1 reference

7 September 2017

Malena Manzi

2

1 reference

7 September 2017

María V Espelt

3

1 reference

7 September 2017

Lucas D Gentilini

4

1 reference

7 September 2017

Daniel Compagno

5

1 reference

7 September 2017

Diego J Laderach

6

1 reference

7 September 2017

Carlota Wolfenstein-Todel

7

1 reference

7 September 2017

Gabriel A Rabinovich

8

1 reference

7 September 2017

María F Troncoso

9

1 reference

7 September 2017

publication date

1 June 2015

1 reference

Journal of Cellular Physiology

7 September 2017

published in

1 reference

7 September 2017

volume

230

1 reference

7 September 2017

issue

6

1 reference

7 September 2017

page(s)

1298-1309

1 reference

Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma

7 September 2017

cites work

1 reference

Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern

21 January 2018

1 reference

Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion

21 January 2018

1 reference

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors

21 January 2018

1 reference

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma

21 January 2018

1 reference

Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease

21 January 2018

1 reference

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

21 January 2018

1 reference

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

21 January 2018

1 reference

Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival

21 January 2018

1 reference

Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth.

21 January 2018

1 reference

Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity

21 January 2018

1 reference

Epithelial-mesenchymal transition in the liver.

21 January 2018

1 reference

Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling

21 January 2018

1 reference

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

21 January 2018

1 reference

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

21 January 2018

1 reference

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

21 January 2018

1 reference

Induction of galectin-1 by TGF-β1 accelerates fibrosis through enhancing nuclear retention of Smad2.

21 January 2018

1 reference

Removal of endotoxin from recombinant protein preparations.

21 January 2018

1 reference

The ins and outs of the epithelial to mesenchymal transition in health and disease

21 January 2018

1 reference

Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways

21 January 2018

1 reference

Galectin-1 and Galectin-3 Mediate Protocadherin-24-Dependent Membrane Localization of β-catenin in Colon Cancer Cell Line HCT116

21 January 2018

1 reference

Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation

21 January 2018

1 reference

Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis

21 January 2018

1 reference

Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation

21 January 2018

1 reference

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege

21 January 2018

1 reference

EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.

21 January 2018

1 reference

Implication of galectin-3 in Wnt signaling.

21 January 2018

1 reference

Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness

21 January 2018

1 reference

The epithelial polarity program: machineries involved and their hijacking by cancer.

21 January 2018

1 reference

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

Epithelial-mesenchymal transition in hepatocellular carcinoma.

21 January 2018

1 reference

Medical therapies for hepatocellular carcinoma: a critical view of the evidence

21 January 2018

1 reference

The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes

21 January 2018

1 reference

Cell polarity in development and cancer.

21 January 2018

1 reference

Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons

21 January 2018

1 reference

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.

21 January 2018

1 reference

Galectins: structure, function and therapeutic potential

21 January 2018

1 reference

Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.24865

1 reference

7 September 2017

1 reference